Person:
BAYRAMİÇLİ, MEHMET NURİ ÜMİT

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

BAYRAMİÇLİ

First Name

MEHMET NURİ ÜMİT

Name

Filters

2010 - 20203
Reset filters

Settings

Author: DURMUŞ KOCAASLAN, FATMA NİHAL × Start date: 2010 ×

Search Results

Now showing 1 - 3 of 3
  • No Thumbnail Available
    PublicationMetadata only
    Elde skuamöz hücreli karsinom ile birlikte aksiller lenf nodlarında foliküler lenfoma
    (2010-09-19) AKDENİZ DOĞAN, ZEYNEP DENİZ; DURMUŞ KOCAASLAN, FATMA NİHAL; BAYRAMİÇLİ, MEHMET NURİ ÜMİT; AKDENİZ DOĞAN Z. D., DURMUŞ KOCAASLAN F. N., ERSOY B., DEMİRKESEN C., BAYRAMİÇLİ M. N. Ü.
  • No Thumbnail Available
    PublicationMetadata only
    Margin-Controlled, Staged Surgical Excision in the Treatment of High-Risk Basal Cell Carcinomas of the Head and Neck Region
    (SAGE PUBLICATIONS INC, 2019) SALMAN, ANDAÇ; Ucar, Ayse Nigar Durmus; Kocaaslan, Fatma Nihal Durmus; Salman, Andac; Demirkesen, Cuyan; Bayram, Filiz Erdem; Bayramicli, Mehmet
    Background: The most common skin cancer is basal cell carcinoma (BCC), and the gold-standard treatment for high-risk tumours is Mohs surgery. However, alternative methods are needed for high-risk tumours in countries where the performance rate of Mohs surgery is low. Objectives: The objective of this article is to investigate the feasibility, efficacy, and safety of margin-controlled, staged surgical excision (MCSSE) in high-risk tumours as a possible treatment alternative. Methods: A retrospective cohort study, including patients diagnosed with high-risk BCC in the head and neck region and treated with MCSSE between 2003 and 2010, was conducted. Results: During the study period 50 tumours in 47 patients were treated, with low adverse event rates and high patient satisfaction rates. Of the 50 tumours, 1 recurred at the 12-month follow-up. Conclusions: Despite the small sample size and relatively short follow-up period, the present study shows that MCSSE might be a feasible alternative for the treatment of high-risk BCCs in institutions where Mohs surgery is not performed. Future studies on long-term recurrence rates are needed.
  • Thumbnail Image
    PublicationOpen Access
    Fat graft survival inside pocket for silicone implant
    (MARMARA UNIV, FAC MEDICINE, 2020-05-31) DURMUŞ KOCAASLAN, FATMA NİHAL; Kocaaslan, Fatma Nihal Durmus; Ozkan, Melekber Cavus; Tuncer, Fatma Betul; Bayramicli, Mehmet
    Objective: The aim of this study was to investigate the survival potential of the fat grafts inside the implant capsule in an experimental setting. Materials and Methods: Twenty male Wistar albino rats were used. A two-staged surgical procedure was performed. In the first stage, silicone sheets were placed in the subcutaneous plane on the left side of each rat. On day 60, fat grafts injected into the silicone capsule either by removing the silicone sheaths or leaving the silicone sheaths in their place. In both groups, the same amount of the fat grafts was injected into the right side of the dorsal subcutaneous plane of the rats and they served as their own controls. The findings were evaluated according to the histopathological criteria. Results: There was no statistically significant difference in the inflammatory cell infiltration, fibrosis, and necrotic adipocytes among the groups. Although, the fat viability rate was higher in control groups, there was no statistically significant difference compared to the capsule or silicone groups (p>0.05). Conclusion: Our study results suggest that implant capsule is a hospitable environment and resection of the capsule is unnecessary, if silicone implants are expected to be removed following fat injection.